BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790 AND Prognosis
7 results:

  • 1. tet2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling.
    Zhang X; Li S; He J; Jin Y; Zhang R; Dong W; Lin M; Yang Y; Tian T; Zhou Y; Xu Y; Lei QY; Zhang J; Zhang Q; Xu Y; Lv L
    Cancer Res; 2022 Jun; 82(11):2097-2109. PubMed ID: 35176127
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
    Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
    Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
    Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
    [No Abstract]    [Full Text] [Related]  

  • 4. Mutation of the PTCH1 gene predicts recurrence of breast cancer.
    Wang CY; Chang YC; Kuo YL; Lee KT; Chen PS; Cheung CHA; Chang CP; Phan NN; Shen MR; Hsu HP
    Sci Rep; 2019 Nov; 9(1):16359. PubMed ID: 31704974
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
    Tsai KW; Li GC; Chen CH; Yeh MH; Huang JS; Tseng HH; Fu TY; Liou HH; Pan HW; Huang SF; Chen CC; Chang HY; Ger LP; Chang HT
    Breast Cancer Res Treat; 2015 Aug; 153(1):219-34. PubMed ID: 26253945
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Reduced Expression of TET1, tet2, TET3 and TDG mRNAs Are Associated with Poor prognosis of Patients with Early breast cancer.
    Yang L; Yu SJ; Hong Q; Yang Y; Shao ZM
    PLoS One; 2015; 10(7):e0133896. PubMed ID: 26207381
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The CpG island methylator phenotype: what's in a name?
    Hughes LA; Melotte V; de Schrijver J; de Maat M; Smit VT; Bovée JV; French PJ; van den Brandt PA; Schouten LJ; de Meyer T; van Criekinge W; Ahuja N; Herman JG; Weijenberg MP; van Engeland M
    Cancer Res; 2013 Oct; 73(19):5858-68. PubMed ID: 23801749
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.